PBT Permian posts narrow Q3 2009 earnings miss shares rise modestly on stable core royalty operations Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval PNI Pimco New reports quarterly earnings with no disclosed core financial metrics leaving investors seeking more operational clarity